NPC1 and nasopharyngeal carcinoma: We have previously reported the synthesis and cholesterol mobilization from endo-lysosomal compartments of NPC1 cells by β-cyclodextrin (β-CD)-based polyrotaxanes (PR) as potential NPC therapeutics [12–15]; findings that were subsequently corroborated using compounds of similar structure [16, 17].